![Craig Jalbert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Craig Jalbert
Amministratore Delegato presso
CARISMA THERAPEUTICS, INC.
Profilo
Craig R.
Jalbert currently serves as President, CEO, CFO, Secretary, Treasurer, Director, and CAO in multiple companies including Carisma Therapeutics, Inc. (since 2026), Unity Biotechnology, Inc. (since 2025), Evelo Biosciences, Inc. (since 2023), eFFECTOR Therapeutics, Inc. (since 2024), TRACON Pharmaceuticals, Inc. (since 2024), NexImmune, Inc. (since 2024), TFF Pharmaceuticals, Inc. (since 2024), Better Therapeutics, Inc. (since 2025), T2 Biosystems, Inc. (since 2025), Rubius Therapeutics, Inc. (since 2023), and holds director roles at CohBar, Inc. (since 2023).
Also holds leadership roles at Seaside Therapeutics LLC, Mitralign, Inc., Avenge Bio, Inc., Aerami Therapeutics Holdings, Inc., and has been Principal at Verdolino & Lowey PC since 1987.
Former roles include Chief Executive Officer, CFO, and Director at Agritech Worldwide, Inc.; President, CEO, CFO, Secretary, Treasurer, and CAO at MZT Holdings, Inc. from 2010 to 2012; President, CEO, Secretary, Treasurer, and Director at Axcella Health, Inc., Molecular Templates, Inc., Bellerophon Therapeutics, Inc., Viracta Therapeutics, Inc., Cambridge Heart, Inc., Dendreon Corp., SIONEX Corp., and CompuCyte Corp.; President, Secretary, Treasurer, and Director at Fetco Home Decor, Inc. and Matritech, Inc.; President, Secretary, Treasurer, and Director at Aptinyx, Inc. in 2023; Director at Oncorus, Inc. in 2023; and President, Secretary, and Treasurer at Ibis Technology Corp.
from 2009 to 2012.
Posizioni attive di Craig Jalbert
| Società | Posizione | Inizio |
|---|---|---|
| RUBIUS THERAPEUTICS | Presidente | 04/03/2023 |
| COHBAR | Direttore/Membro del Consiglio | 06/11/2023 |
| EVELO BIOSCIENCES, INC. | Amministratore Delegato | 21/11/2023 |
| BETTER THERAPEUTICS, INC. | Amministratore Delegato | 14/03/2025 |
| EFFECTOR THERAPEUTICS, INC. | Amministratore Delegato | 21/06/2024 |
| TRACON PHARMACEUTICALS, INC. | Amministratore Delegato | 31/07/2024 |
| NEXIMMUNE, INC. | Amministratore Delegato | 27/08/2024 |
| TFF PHARMACEUTICALS, INC. | Amministratore Delegato | 14/11/2024 |
| T2 BIOSYSTEMS, INC. | Amministratore Delegato | 03/04/2025 |
| ░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░ | - |
Precedenti posizioni note di Craig Jalbert
| Società | Posizione | Fine |
|---|---|---|
| ░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░ | ░░░░░░░░░░ | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
51
Relazioni di 1° grado
31
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 31 |
|---|---|
Matritech, Inc.
 Matritech, Inc. Medical SpecialtiesHealth Technology Develops innovative cancer diagnostic products | Health Technology |
Ibis Technology Corp.
 Ibis Technology Corp. SemiconductorsElectronic Technology Develops, manufactures, and markets semiconductors | Electronic Technology |
Cambridge Heart, Inc.
 Cambridge Heart, Inc. Medical SpecialtiesHealth Technology Engages in research, development and commercialization of products for the non-invasive diagnosis of cardiac disease | Health Technology |
Agritech Worldwide, Inc.
 Agritech Worldwide, Inc. Food: Major DiversifiedConsumer Non-Durables Manufactures multifunctional dietary fiber ingredients for the food industry | Consumer Non-Durables |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes novel products for the treatment of cancer | Health Technology |
SIONEX Corp.
 SIONEX Corp. Electronic Equipment/InstrumentsElectronic Technology Develops chemical and biological sensor chips and systems | Electronic Technology |
Mitralign, Inc.
 Mitralign, Inc. Medical SpecialtiesHealth Technology Engages in the development of medical devices | Health Technology |
TRACON Pharmaceuticals, Inc.
 TRACON Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel targeted therapeutics for cancer treatment | Health Technology |
CohBar, Inc.
 CohBar, Inc. BiotechnologyHealth Technology Develops biotechnology products that intends to treat age-related diseases through the discovery of novel mitochondrial-derived peptides | Health Technology |
NexImmune, Inc.
 NexImmune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops T cell immunotherapies | Health Technology |
Aerami Therapeutics Holdings, Inc.
 Aerami Therapeutics Holdings, Inc. Medical SpecialtiesHealth Technology Develops inhaled insulin devices | Health Technology |
Bellerophon Therapeutics, Inc.
 Bellerophon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products to treat cardiopulmonary diseases | Health Technology |
CompuCyte Corp.
 CompuCyte Corp. Medical SpecialtiesHealth Technology Develops laser scanning products | Health Technology |
Fetco Home Decor, Inc.
 Fetco Home Decor, Inc. Home FurnishingsConsumer Durables Manufactures photo frames and home decorative items | Consumer Durables |
MZT Holdings, Inc.
 MZT Holdings, Inc. Medical SpecialtiesHealth Technology Develops cancer diagnostic products | Health Technology |
T2 Biosystems, Inc.
 T2 Biosystems, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
Seaside Therapeutics LLC
 Seaside Therapeutics LLC Medical DistributorsDistribution Services Develops drug treatments to correct or improve the course of fragile x syndrome | Distribution Services |
Verdolino & Lowey PC
 Verdolino & Lowey PC Miscellaneous Commercial ServicesCommercial Services Verdolino & Lowey PC is a professional services firm specializing in a broad spectrum of financial, advisory, and forensic services tailored to businesses, individuals, nonprofits, political campaigns, and high-net-worth clients. The private company is based in Foxborough, MA. The company offers expertise in bankruptcy and insolvency, including chapter 11 representation, fiduciary and trustee roles, debt restructuring, claims administration, and business wind-down and liquidation services. Its capabilities include accounting and business advisory, tax planning and compliance, litigation support, forensic accounting, and computer forensics conducted by certified examiners to support investigations and legal proceedings. Verdolino & Lowey also provides specialized services for nonprofit organizations, focusing on financial management, tax-exemption compliance, fundraising support, and transparent reporting, as well as campaign finance services that ensure regulatory compliance and accurate financial reporting for political candidates and PACs. | Commercial Services |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Develops red cell therapeutics for cancer treatment | Health Technology |
Aptinyx, Inc.
 Aptinyx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapies to treat disorders of the brain and nervous system | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. BiotechnologyHealth Technology Engages in the research and development of therapeutics to extend the human healthspan | Health Technology |
Oncorus, Inc.
 Oncorus, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops next generation immunotherapy platform to treat cancer | Health Technology |
Molecular Templates, Inc.
 Molecular Templates, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company | Commercial Services |
TFF Pharmaceuticals, Inc.
 TFF Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures inhaled dry powder drugs for the treatment of pulmonary diseases and conditions | Health Technology |
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immuno-oncology company | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
eFFECTOR Therapeutics, Inc.
 eFFECTOR Therapeutics, Inc. BiotechnologyHealth Technology Operates as a oncology company which develops therapies for cancer | Health Technology |
Better Therapeutics, Inc.
 Better Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases | Health Technology |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
